Homepage
Author:
HAEMONETICS CORPORATION
Posted Date:
April 1, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
HAEMONETICS CORPORATION
April 1, 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
HAEMONETICS CORPORATION
March 30, 2026
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
HAEMONETICS CORPORATION
February 23, 2026
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
HAEMONETICS CORPORATION
February 20, 2026
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
HAEMONETICS CORPORATION
February 7, 2026
